NYSE: GGenpact Ltd Stock
$45.44+0.60 (+1.34%)
Updated Mar 21, 2023
G Price
$45.44
Fair Value Price
N/A
Market Cap
$8.36B
52 Week Low
$37.68
52 Week High
$48.85
P/E
23.67x
P/B
4.58x
P/S
1.95x
PEG
0.69x
Dividend Yield
1.13%
Revenue
$4.37B
Earnings
$353.40M
Gross Margin
35.1%
Operating Margin
11.84%
Profit Margin
8.1%
Debt to Equity
1.51
Operating Cash Flow
$444M
Beta
0.97
Next Earnings
May 3, 2023
Ex-Dividend
Mar 9, 2023
Next Dividend
Mar 24, 2023
G Overview
Genpact Limited offers business process management services including aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Its clients are in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact operates but generates most of its revenue in India. Genpact was founded in 1997 and is headquartered in New York City, NY.
Zen Score
–
Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how G scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
G ($45.44) is trading above its intrinsic value of $34.51, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
G is poor value based on its earnings relative to its share price (23.67x), compared to the US market average (22.45x)
P/E vs Market Valuation
G is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more G due diligence checks available for Premium users.
Be the first to know about important G news, forecast changes, insider trades & much more!
G News
Valuation
G price to earnings (PE)
For valuing profitable companies with steady earnings
Company
23.67x
Industry
27.84x
Market
22.45x
G is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
G is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
G price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.58x
Industry
3.56x
G is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
G price to earnings growth (PEG)
For valuing profitable companies with growth potential
G is good value based... subscribe to Premium to read more.
PEG Value Valuation
G's financial health
Profit margin
Revenue
$1.1B
Net Income
$89.7M
Profit Margin
8.1%
G's Earnings (EBIT) of $517.44M... subscribe to Premium to read more.
Interest Coverage Financials
G's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.6B
Liabilities
$2.8B
Debt to equity
1.51
G's short-term assets ($1.78B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
G's short-term assets ($1.78B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
G's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
G's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$229.6M
Investing
$660.0k
Financing
-$100.2M
G's operating cash flow ($443.67M)... subscribe to Premium to read more.
Debt Coverage Financials
G vs Information Technology Service Stocks
Genpact Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.